Cargando…

An Integrative Pharmacology Based Analysis of Refined Liuweiwuling Against Liver Injury: A Novel Component Combination and Hepaprotective Mechanism

Liver disease is a major cause of illness and death worldwide. In China, liver diseases, primarily alcoholic and nonalcoholic fatty liver disease, and viral hepatitis, affect approximately 300 million people, resulting in a major impact on the global burden of liver diseases. The use of Liuweiwuling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yuan, Shi, Wei, Yao, Hongyu, Ai, Yongqiang, Li, Ruisheng, Wang, Zhilei, Liu, Tingting, Dai, Wenzhang, Xiao, Xiaohe, Zhao, Jun, Niu, Ming, Bai, Zhaofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493075/ https://www.ncbi.nlm.nih.gov/pubmed/34630116 http://dx.doi.org/10.3389/fphar.2021.747010

Ejemplares similares

Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats
por: Liu, Huimin, et al.
Publicado: (2018)

The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice
por: Ai, Yongqiang, et al.
Publicado: (2021)

Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis via Modulating Multiple Signaling Pathways in Mice
por: Ai, Yongqiang, et al.
Publicado: (2021)

Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
por: Liu, Tingting, et al.
Publicado: (2022)

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
por: Li, Zhiyong, et al.
Publicado: (2021)

A systems pharmacology-oriented discovery of a new therapeutic use of the TCM formula Liuweiwuling for liver failure
por: Wang, Jia-bo, et al.
Publicado: (2018)

Aripiprazole-induced liver injury: a spontaneous reporting database study
por: Gao, Yunjuan, et al.
Publicado: (2023)

Hepaprotective Effect of Standardized Ecklonia stolonifera Formulation on CCl(4)-Induced Liver Injury in Sprague-Dawley Rats
por: Byun, Jae-Hyuk, et al.
Publicado: (2018)

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
por: Ge, Fei-lin, et al.
Publicado: (2021)

NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
por: Wang, Zhilei, et al.
Publicado: (2022)

Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation
por: Mu, Wenqing, et al.
Publicado: (2023)

Curdione and Schisandrin C Synergistically Reverse Hepatic Fibrosis via Modulating the TGF-β Pathway and Inhibiting Oxidative Stress
por: Dai, Wenzhang, et al.
Publicado: (2021)

Refining Pharmacologic Research to Prevent and Treat Spontaneous Preterm Birth
por: Manuck, Tracy A.
Publicado: (2017)

Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome
por: Wang, Zhilei, et al.
Publicado: (2019)

Author correction to ‘Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome’ [Acta Pharmaceutica Sinica B 9 (2019) 734–744]
por: Wang, Zhilei, et al.
Publicado: (2020)

Immunostimulatory activity and structure-activity relationship of epimedin B from Epimedium brevicornu Maxim.
por: Gao, Yuan, et al.
Publicado: (2022)

The Cytosolic DNA-Sensing cGAS-STING Pathway in Liver Diseases
por: Wang, Zhilei, et al.
Publicado: (2021)

Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients: A retrospective cohort study
por: Fang, Zhi-e, et al.
Publicado: (2022)

The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
por: Zhan, Xiaoyan, et al.
Publicado: (2023)

Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza
por: Jiang, Zhouqian, et al.
Publicado: (2019)

Licorice extract inhibits the cGAS-STING pathway and protects against non-alcoholic steatohepatitis
por: Luo, Wei, et al.
Publicado: (2023)

Bupleurum marginatum Wall.ex DC in Liver Fibrosis: Pharmacological Evaluation, Differential Proteomics, and Network Pharmacology
por: Liu, Xiujie, et al.
Publicado: (2018)

Characterization of the Components and Pharmacological Effects of Mountain-Cultivated Ginseng and Garden Ginseng Based on the Integrative Pharmacology Strategy
por: Li, Sen, et al.
Publicado: (2021)

Natural Medicines for the Treatment of Epilepsy: Bioactive Components, Pharmacology and Mechanism
por: He, Li-Ying, et al.
Publicado: (2021)

Active Components and Pharmacological Effects of Cornus officinalis: Literature Review
por: Gao, Xue, et al.
Publicado: (2021)

Icariside Ⅱ, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation
por: Wang, Zhilei, et al.
Publicado: (2020)

Caffeine in liver diseases: Pharmacology and toxicology
por: Shan, Liang, et al.
Publicado: (2022)

Dihydrotanshinone I Specifically Inhibits NLRP3 Inflammasome Activation and Protects Against Septic Shock In Vivo
por: Wei, Ziying, et al.
Publicado: (2021)

Pharmacological activities and effective substances of the component-based Chinese medicine of Ginkgo biloba leaves based on serum pharmacochemistry, metabonomics and network pharmacology
por: Liang, Hongbao, et al.
Publicado: (2023)

An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid
por: Ma, Chongyang, et al.
Publicado: (2020)

Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective
por: Shi, Peiying, et al.
Publicado: (2022)

Ganoderma lucidum: Current advancements of characteristic components and experimental progress in anti-liver fibrosis
por: Peng, Haoyuan, et al.
Publicado: (2023)

Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases
por: Shi, Wei, et al.
Publicado: (2020)

Uncovering the Pharmacological Mechanisms of Gexia-Zhuyu Formula (GXZY) in Treating Liver Cirrhosis by an Integrative Pharmacology Strategy
por: Cao, Xu, et al.
Publicado: (2022)

Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics
por: Shang, Xiaofei, et al.
Publicado: (2022)

Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis
por: Li, Le, et al.
Publicado: (2023)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Icariside I specifically facilitates ATP or nigericin-induced NLRP3 inflammasome activation and causes idiosyncratic hepatotoxicity
por: Gao, Yuan, et al.
Publicado: (2021)

Pharmacological effects of natural medicine ginsenosides against Alzheimer’s disease
por: Shi, Zhikun, et al.
Publicado: (2022)

Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods
por: Shenoy, Priyank, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p2qpfa53liqp5vnfbkm3j857ic